csl
The struggling healthcare giant reported a sharp drop in sales at its Vifor kidney business, but expects underlying earnings to increase 5 per cent this year.
Peak volume
2K+
First seen
2026-08-18
Last seen
2026-08-18
Days trending
1 / 1
Countries
1
Trending timeline
Latest related news (2026-08-18)
-
CSL’s shares rocket on better than expected guidance; Reliance soars — The Australian
-
-
CSL earnings: FY26 sees reset and path to future growth — The Motley Fool Australia